Literature DB >> 31275071

Management of Complex Anorectal and Perianal Crohn's Disease.

Vladimir Bolshinsky1, James Church1.   

Abstract

Perianal symptoms occur in up to 50% of patients with Crohn's disease in other parts of the gastrointestinal tract, and in 5% of patients it is the first manifestation of the disease. The perianal area is often under stress in patients with Crohn's disease, because of the diarrhea, and the fecal urgency, frequency, and incontinence caused by proximal disease. Symptomatic perianal disease can therefore be due to the effects of the stress on an otherwise normal anus, or the result of Crohn's disease in the low rectum and/or perianal tissues themselves. This key distinction should drive the investigation and management of anal and perianal symptoms in patients with Crohn's disease. In this review, the evaluation and management of the various manifestations of Crohn's disease in the perineum and perianal tissues will be described.

Entities:  

Keywords:  anal fissure; anorectal fistula; perianal Crohn's disease

Year:  2019        PMID: 31275071      PMCID: PMC6606315          DOI: 10.1055/s-0039-1683907

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  15 in total

1.  Open sesame: tips for traversing the anal canal.

Authors:  K C Farmer; J M Church
Journal:  Dis Colon Rectum       Date:  1992-11       Impact factor: 4.585

2.  Advancement flap repair: a good option for complex anorectal fistulas.

Authors:  Awad Jarrar; James Church
Journal:  Dis Colon Rectum       Date:  2011-12       Impact factor: 4.585

3.  Perianal Crohn's disease findings other than fistulas in a population-based cohort.

Authors:  Laurent Peyrin-Biroulet; Edward V Loftus; William J Tremaine; W Scott Harmsen; Alan R Zinsmeister; William J Sandborn
Journal:  Inflamm Bowel Dis       Date:  2011-02-23       Impact factor: 5.325

Review 4.  Systematic review: the combined surgical and medical treatment of fistulising perianal Crohn's disease.

Authors:  N A Yassin; A Askari; J Warusavitarne; O D Faiz; T Athanasiou; R K S Phillips; A L Hart
Journal:  Aliment Pharmacol Ther       Date:  2014-08-13       Impact factor: 8.171

Review 5.  Is haemorrhoidectomy in inflammatory bowel disease harmful? An old dogma re-examined.

Authors:  N Cracco; R Zinicola
Journal:  Colorectal Dis       Date:  2014-07       Impact factor: 3.788

Review 6.  Systematic review: The safety and efficacy of hyperbaric oxygen therapy for inflammatory bowel disease.

Authors:  P S Dulai; M W Gleeson; D Taylor; S D Holubar; J C Buckey; C A Siegel
Journal:  Aliment Pharmacol Ther       Date:  2014-04-16       Impact factor: 8.171

7.  The spectrum of perianal Crohn's disease in a population-based cohort.

Authors:  Tim W Eglinton; Murray L Barclay; Richard B Gearry; Frank A Frizelle
Journal:  Dis Colon Rectum       Date:  2012-07       Impact factor: 4.585

8.  Biological immunomodulators improve the healing rate in surgically treated perianal Crohn's fistulas.

Authors:  G El-Gazzaz; T Hull; J M Church
Journal:  Colorectal Dis       Date:  2012-10       Impact factor: 3.788

9.  Perineal Crohn's disease: an indicator of poor prognosis and potential proctectomy.

Authors:  Ryan E Figg; James M Church
Journal:  Dis Colon Rectum       Date:  2009-04       Impact factor: 4.585

Review 10.  Systematic review with meta-analysis: faecal diversion for management of perianal Crohn's disease.

Authors:  S Singh; N S Ding; K L Mathis; P S Dulai; A M Farrell; J H Pemberton; A L Hart; W J Sandborn; E V Loftus
Journal:  Aliment Pharmacol Ther       Date:  2015-08-11       Impact factor: 8.171

View more
  2 in total

Review 1.  Modern surgical strategies for perianal Crohn's disease.

Authors:  Gilmara Pandolfo Zabot; Ornella Cassol; Rogerio Saad-Hossne; Willem Bemelman
Journal:  World J Gastroenterol       Date:  2020-11-14       Impact factor: 5.742

2.  From high volume to "zero" proctology: Italian experience in the COVID era.

Authors:  Domenico Mascagni; Chiara Eberspacher; Pietro Mascagni; Alberto Arezzo; Francesco Selvaggi; Alessandro Sturiale; Giovanni Milito; Gabriele Naldini
Journal:  Int J Colorectal Dis       Date:  2020-05-29       Impact factor: 2.571

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.